Additionally, three previously identified biomarkers, OLFM4, HDGF, and GDF15, were validated as diagnostic biomarkers for HCC, showcasing the ability to diagnose HCC and potentially recognize the ER of HCC in a noninvasive, reproducible, and reliable manner. This evidence concerns the gene GDF15 and hepatocellular carcinoma.